Research suggests that Pygeum africanum shows promising results for prostate health across several areas, including potential benefits for benign prostatic hyperplasia (BPH) symptom relief and possible chemopreventive properties against prostate cancer. The available evidence includes one preclinical study using cell culture and an animal model, which found that a Pygeum africanum extract inhibited prostate cancer cell growth and reduced tumor development rates in mice compared to controls, and two review articles that characterize the overall evidence for this botanical as favorable and promising within the broader landscape of plant-based prostate interventions. Studies indicate that reviewers generally group Pygeum africanum alongside other botanicals like stinging nettle and beta-sitosterols as showing more consistent positive signals for prostate health than some other commonly used supplements. However, the current body of evidence summarized here is limited in depth — relying on reviews and preclinical rather than large-scale human clinical trials — so readers should be aware that stronger evidence from well-controlled human studies would be needed to draw firm conclusions about its effectiveness.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Phytosterol Pygeum africanum regulates prostate cancer in vitro and in vivo. | Other | 2007 | Supports | 100 |
| Beyond tribulus (Tribulus terrestris L.): The effects of phytotherapics on te... | Review | 2019 | Supports | 95 |
| Flavonoid and botanical approaches to prostate health. | Review | 2002 | Supports | 90 |